LncRNA HNF1A-AS1通过E2F1上调OTUD7A的表达促进胰腺癌干性的机制研究
批准号:
82103681
项目类别:
青年科学基金项目(C类)
资助金额:
30.0 万元
负责人:
雷珊
依托单位:
学科分类:
肿瘤干细胞
结题年份:
2024
批准年份:
2021
项目状态:
已结题
项目参与者:
雷珊
中文摘要
癌干细胞是导致肿瘤转移复发的主要原因之一,胰腺癌中癌干细胞比例相对较高,导致其预后不良。然而,胰腺癌干细胞高比例的调控机制目前还不清楚。我们构建胰腺癌悬浮球细胞作为胰腺癌干细胞模型,通过转录组测序发现HNF1A-AS1在该细胞中表达上调。对HNF1A-AS1进行过表达,可增加胰腺癌细胞干性表型。通过pull down联合质谱分析,发现HNF1A-AS1能与E2F1相互作用,促进OTUD7A表达,OTUD7A可减少干性基因CD133的泛素化,但其泛素化机制不清楚。因此申请人提出科研假设: HNF1A-AS1通过结合并增加E2F1的转录稳定性,增强E2F1介导的OTUD7A转录,进而减少CD133泛素化,促进胰腺癌干性。本研究探讨HNF1A-AS1对胰腺癌干性的影响,并深入解析CD133形成的复合物及OTUD7A对CD133的泛素化及去泛素化机制,为临床克服胰腺癌干性提供新的思路。
英文摘要
Cancer stem cells are one of the main causes of tumor metastasis and recurrence. The proportion of cancer stem cells in pancreatic cancer is relatively high, leading to poor prognosis. However, the regulatory mechanism of the high proportion of pancreatic cancer stem cells is still unclear. We constructed pancreatic cancer suspension spheres cells as a pancreatic cancer stem cell model, and transcriptome sequencing showed that HNF1A-AS1 was up-regulated in these cells. Overexpression of HNF1A-AS1 increased the stemness of pancreatic cancer cells. Through pull down combined mass spectrometry analysis, it was found that HNF1A-AS1 binds with E2F1 to promote the expression of OTUD7A, and OTUD7A reduced the ubiquitination of stemness gene CD133. However, its ubiquitination mechanism was not fully understood. Therefore, the applicant proposes a scientific hypothesis: HNF1A-AS1 enhances E2F1-mediated OTUD7A transcription by binding and increasing the transcriptional stability of E2F1, thereby reducing CD133 ubiquitination and promoting pancreatic cancer stemness. In this study, the effect of HNF1A-AS1 on the stemness of pancreatic cancer was explored, the complex formed by CD133 and the mechanism of CD133 ubiquitination and deubiquitination by OTUD7A were further analyzed, providing a novel strategy for overcoming the stemness of pancreatic cancer.
胰腺癌(PC)是一种高度恶性的消化系统肿瘤,具有显著的侵袭性和耐药性。胰腺癌干细胞在肿瘤进展中起着至关重要的作用,但PC干细胞的调控尚不完全清楚。采用RNA测序技术鉴定高干性PC细胞中差异表达的长链非编码RNA (lncRNAs),并采用原位杂交技术检测PC样品中HNF1A-AS1的表达。为了评估HNF1A-AS1对细胞干细胞性的影响,我们进行了体外和体内功能测定。此外,采用RNA pull-down和染色质免疫沉淀法分析HNF1A-AS1、E2F1/MLL复合物和Nanog之间的分子相互作用。设计并包装了靶向反义寡核苷酸(ASOs)的HNF1A-AS1,并对其生物学效应进行了综合评价。HNF1A-AS1在PC细胞中表达显著上调,表现出高干性,且其在PC组织中的表达高于邻近组织。HNF1A-AS1基因敲低可降低PC细胞的干性表型,降低Nanog靶基因的表达。HNF1A-AS1在PC细胞中与转录因子E2F1相互作用。这种相互作用促进了MLL复合体向Nanog启动子的招募,增强了其表达。恢复E2F1或Nanog可抵消HNF1A-AS1敲低的影响。本研究表明,lncRNA HNF1A-AS1通过募集E2F1/MLL复合物上调Nanog转录来促进PC的干细胞性。靶向HNF1A-AS1是治疗PC的一种有前景的治疗策略。
MEF2A调控RHOA启动子区组蛋白甲基化修饰促进胰腺癌转移的机制研究
-
批准号:82560509
-
项目类别:地区科学基金项目
-
资助金额:32.00万元
-
批准年份:2025
-
负责人:雷珊
-
依托单位:
国内基金
海外基金